{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:42:53Z","timestamp":1788554573146,"version":"build-2803163510"},"reference-count":66,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAR"],"DOI":"10.2147\/cmar.s271442","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:05:06Z","timestamp":1671757506000},"page":"3527-3538","source":"Crossref","is-referenced-by-count":15,"title":["Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported Outcomes"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Yenny","family":"Moreno Vanegas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1548-918X","authenticated-orcid":true,"given":"Talha","family":"Badar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.leukres.2015.10.005","volume":"39","author":"Badar","year":"2015","journal-title":"Leuk Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1080\/10428194.2020.1719089","volume":"61","author":"Badar","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41408-020-00376-1","volume":"10","author":"Daver","year":"2020","journal-title":"Blood Cancer J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/j.clml.2015.03.012","volume":"15","author":"Badar","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1182\/bloodadvances.2020001779","volume":"4","author":"Zeidan","year":"2020","journal-title":"Blood Adv"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S1470-2045(21)00494-0","volume":"22","author":"DiNardo","year":"2021","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijms23073887","volume":"23","author":"Andreozzi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/13543784.2021.1915986","volume":"30","author":"Badar","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.2165\/11209430-000000000-00000","volume":"72","author":"Keating","year":"2012","journal-title":"Drugs"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.4161\/epi.5.8.13105","volume":"5","author":"Bernstein","year":"2010","journal-title":"Epigenetics"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm4010001","volume":"4","author":"Cruijsen","year":"2014","journal-title":"J Clin Med"},{"key":"ref14","first-page":"1324","volume":"87","author":"Leone","year":"2002","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/0091270004271947","volume":"45","author":"Marcucci","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/phar.1371","volume":"34","author":"Laille","year":"2014","journal-title":"Pharmacotherapy"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1200\/JCO.2005.05.4346","volume":"24","author":"Silverman","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/cncr.21792","volume":"106","author":"Kantarjian","year":"2006","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.critrevonc.2017.05.010","volume":"116","author":"Schuh","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","volume":"10","author":"Fenaux","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1182\/blood-2015-01-621664","volume":"126","author":"Dombret","year":"2015","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1200\/JCO.2009.23.8329","volume":"28","author":"Fenaux","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.leukres.2013.02.014","volume":"37","author":"Bally","year":"2013","journal-title":"Leuk Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2162-3619-3-10","volume":"3","author":"Smith","year":"2014","journal-title":"Exp Hematol Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ajh.23654","volume":"89","author":"Th\u00e9pot","year":"2014","journal-title":"Am J Hematol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00277-014-2126-9","volume":"93","author":"Pleyer","year":"2014","journal-title":"Ann Hematol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ajh.23464","volume":"88","author":"Ivanoff","year":"2013","journal-title":"Am J Hematol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/ijms18020415","volume":"18","author":"Pleyer","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/cncr.26354","volume":"118","author":"Maurillo","year":"2012","journal-title":"Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.leukres.2014.11.009","volume":"39","author":"Itzykson","year":"2015","journal-title":"Leuk Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem J"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrd772","volume":"1","author":"Johnstone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.leukres.2004.11.022","volume":"29","author":"Yang","year":"2005","journal-title":"Leuk Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1182\/bloodadvances.2018027409","volume":"3","author":"Garcia-Manero","year":"2019","journal-title":"Blood Adv"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1182\/blood-2019-123237","volume":"134","author":"Badar","year":"2019","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1182\/blood-2003-12-4333","volume":"104","author":"Kuendgen","year":"2004","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00277-005-0026-8","volume":"84","author":"Kuendgen","year":"2005","journal-title":"Ann Hematol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/bjh.18193","volume":"198","author":"Ad\u00e8s","year":"2022","journal-title":"Br J Haematol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/s41375-019-0472-2","volume":"33","author":"Pollyea","year":"2019","journal-title":"Leukemia"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1182\/blood.2021014586","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1182\/blood-2019-126271","volume":"134","author":"Sallman","year":"2019","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1056\/NEJMoa2004444","volume":"383","author":"Wei","year":"2020","journal-title":"N Engl J Med"},{"key":"ref45","unstructured":"Helsinn.com. Helsinn Group and MEI Pharma Discontinue the Phase 3 Study with Pracinostat in AML after Completing Interim Analysis. Available from: https:\/\/helsinn.com\/helsinn-group-and-mei-pharma-discontinue-the-phase-3-study-with-pracinostat-in-aml-after-completing-interim-analysis\/. Accessed December 16, 2022."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/cncr.23789","volume":"113","author":"Raza","year":"2008","journal-title":"Cancer"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1200\/JCO.2010.30.3339","volume":"28","author":"Blum","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/leu.2011.294","volume":"26","author":"Pollyea","year":"2012","journal-title":"Leukemia"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/10428194.2015.1091930","volume":"57","author":"Narayan","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","volume":"10","author":"Konopleva","year":"2006","journal-title":"Cancer Cell"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S1470-2045(18)30010-X","volume":"19","author":"DiNardo","year":"2018","journal-title":"Lancet Oncol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1182\/bloodadvances.2019000243","volume":"3","author":"Winters","year":"2019","journal-title":"Blood Adv"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1182\/bloodadvances.2021005538","volume":"5","author":"Cherry","year":"2021","journal-title":"Blood Adv"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"106803","DOI":"10.1016\/j.leukres.2022.106803","volume":"114","author":"De Bellis","year":"2022","journal-title":"Leuk Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/QCO.0000000000000611","volume":"32","author":"Lindsay","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/leu.2015.346","volume":"30","author":"Chang","year":"2016","journal-title":"Leukemia"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Perl AE, Martinelli G, Cortes JE, et al. Gilteritinib or chemotherapy for relapsed or refractory FLT3mutated AML. doi:10.1056\/NEJMoa1902688","DOI":"10.1056\/NEJMoa1902688"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Short NJ, DiNardo CD, Daver N, et al. A triplet combination of azacitidine, venetoclax and gilteritinib for patients with FLT3mutated acute myeloid leukemia: results from a phase I\/II study. doi:10.1182\/blood-2021-153571","DOI":"10.1182\/blood-2021-153571"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa2117344","volume":"386","author":"Montesinos","year":"2022","journal-title":"N Engl J Med"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","volume":"378","author":"DiNardo","year":"2018","journal-title":"N Engl J Med"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"E232","DOI":"10.1002\/ajh.26546","volume":"97","author":"Badar","year":"2022","journal-title":"Am J Hematol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1200\/JCO.20.02342","volume":"39","author":"Cluzeau","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1182\/blood-2021-145208","volume":"138","author":"Daver","year":"2021","journal-title":"Blood"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1182\/blood.2022016293","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"}],"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=86401","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=86401","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:05:11Z","timestamp":1671757511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/clinical-utility-of-azacitidine-in-the-management-of-acute-myeloid-leu-peer-reviewed-fulltext-article-CMAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":66,"URL":"https:\/\/doi.org\/10.2147\/cmar.s271442","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}